Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structural joint damage at one year - Commentary
托珠单抗
医学
类风湿性关节炎
甲氨蝶呤
安慰剂
随机对照试验
内科学
外科
替代医学
病理
作者
T. Huizinga,Peter A. Nigrović,Eric Ruderman,Hendrik Schulze‐Koops
出处
期刊:International Journal of Advances in Rheumatology日期:2011-12-01卷期号:9 (3): 98-99